Filing metadata

Accession number
0001193125-25-209353
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Sep 19, 2025
Reporting period
Sep 17, 2025
Description
Insider transaction

Explore SEC Filings Hub